294 related articles for article (PubMed ID: 26991794)
1. Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug-induced liver injury case-control study in Italy.
Donati M; Conforti A; Lenti MC; Capuano A; Bortolami O; Motola D; Moretti U; Vannacci A; Rafaniello C; Vaccheri A; Arzenton E; Bonaiuti R; Sportiello L; Leone R;
Br J Clin Pharmacol; 2016 Jul; 82(1):238-48. PubMed ID: 26991794
[TBL] [Abstract][Full Text] [Related]
2. Nonsteroidal anti-inflammatory drug-induced liver injury: a case-control study in primary care.
Lacroix I; Lapeyre-Mestre M; Bagheri H; Pathak A; Montastruc JL; ;
Fundam Clin Pharmacol; 2004 Apr; 18(2):201-6. PubMed ID: 15066135
[TBL] [Abstract][Full Text] [Related]
3. Serious liver injury induced by Nimesulide: an international collaborative study.
Bessone F; Hernandez N; Mendizabal M; Ridruejo E; Gualano G; Fassio E; Peralta M; Fainboim H; Anders M; Tanno H; Tanno F; Parana R; Medina-Caliz I; Robles-Diaz M; Alvarez-Alvarez I; Niu H; Stephens C; Colombato L; Arrese M; Reggiardo MV; Ono SK; Carrilho F; Lucena MI; Andrade RJ
Arch Toxicol; 2021 Apr; 95(4):1475-1487. PubMed ID: 33759010
[TBL] [Abstract][Full Text] [Related]
4. Adverse drug reactions related to the use of NSAIDs with a focus on nimesulide: results of spontaneous reporting from a Northern Italian area.
Conforti A; Leone R; Moretti U; Mozzo F; Velo G
Drug Saf; 2001; 24(14):1081-90. PubMed ID: 11735663
[TBL] [Abstract][Full Text] [Related]
5. Nimesulide-induced hepatotoxicity: A systematic review and meta-analysis.
Kwon J; Kim S; Yoo H; Lee E
PLoS One; 2019; 14(1):e0209264. PubMed ID: 30677025
[TBL] [Abstract][Full Text] [Related]
6. Risk of hospital admission for liver injury in users of NSAIDs and nonoverdose paracetamol: Preliminary results from the EPIHAM study.
Gulmez SE; Unal US; Lassalle R; Chartier A; Grolleau A; Moore N
Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1174-1181. PubMed ID: 30112779
[TBL] [Abstract][Full Text] [Related]
7. Systematic review: ibuprofen-induced liver injury.
Zoubek ME; Lucena MI; Andrade RJ; Stephens C
Aliment Pharmacol Ther; 2020 Mar; 51(6):603-611. PubMed ID: 31984540
[TBL] [Abstract][Full Text] [Related]
8. Increased risk of hospitalization for acute hepatitis in patients with previous exposure to NSAIDs.
Lee CH; Wang JD; Chen PC
Pharmacoepidemiol Drug Saf; 2010 Jul; 19(7):708-14. PubMed ID: 20582911
[TBL] [Abstract][Full Text] [Related]
9. Risk of upper gastrointestinal complications in a cohort of users of nimesulide and other nonsteroidal anti-inflammatory drugs in Friuli Venezia Giulia, Italy.
Castellsague J; Pisa F; Rosolen V; Drigo D; Riera-Guardia N; Giangreco M; Clagnan E; Tosolini F; Zanier L; Barbone F; Perez-Gutthann S
Pharmacoepidemiol Drug Saf; 2013 Apr; 22(4):365-75. PubMed ID: 23229866
[TBL] [Abstract][Full Text] [Related]
10. Nimesulide: patients still exposed to a risk of severe hepatitis.
Prescrire Int; 2011 May; 20(116):125-6. PubMed ID: 21648177
[TBL] [Abstract][Full Text] [Related]
11. Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs.
Traversa G; Bianchi C; Da Cas R; Abraha I; Menniti-Ippolito F; Venegoni M
BMJ; 2003 Jul; 327(7405):18-22. PubMed ID: 12842950
[TBL] [Abstract][Full Text] [Related]
12. Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage?
Bessone F
World J Gastroenterol; 2010 Dec; 16(45):5651-61. PubMed ID: 21128314
[TBL] [Abstract][Full Text] [Related]
13. Fatal hepatoxicity secondary to nimesulide.
Merlani G; Fox M; Oehen HP; Cathomas G; Renner EL; Fattinger K; Schneemann M; Kullak-Ublick GA
Eur J Clin Pharmacol; 2001 Jul; 57(4):321-6. PubMed ID: 11549211
[TBL] [Abstract][Full Text] [Related]
14. Treatment of acute low back pain with the COX-2-selective anti-inflammatory drug nimesulide: results of a randomized, double-blind comparative trial versus ibuprofen.
Pohjolainen T; Jekunen A; Autio L; Vuorela H
Spine (Phila Pa 1976); 2000 Jun; 25(12):1579-85. PubMed ID: 10851109
[TBL] [Abstract][Full Text] [Related]
15. Prescriptions of NSAIDs to patients undergoing third molar surgery : an observational, prospective, multicentre survey.
Levrini L; Carraro M; Rizzo S; Salgarello S; Bertelli E; Pelliccioni GA; Garau V; Bandettini M; Caputi S; Lörincz A; Szûcs A
Clin Drug Investig; 2008; 28(10):657-68. PubMed ID: 18783304
[TBL] [Abstract][Full Text] [Related]
16. Clinical course and outcomes of drug-induced liver injury: nimesulide as the first implicated medication.
Licata A; Calvaruso V; Cappello M; Craxì A; Almasio PL
Dig Liver Dis; 2010 Feb; 42(2):143-8. PubMed ID: 19625223
[TBL] [Abstract][Full Text] [Related]
17. Liver transplantation for nonsteroidal anti-inflammatory drug-induced liver failure: nimesulide as the first implicated compound.
Dastis SN; Rahier J; Lerut J; Geubel AP
Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):919-22. PubMed ID: 18049158
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for acetaminophen and nimesulide intolerance in patients with NSAID-induced skin disorders.
Asero R
Ann Allergy Asthma Immunol; 1999 Jun; 82(6):554-8. PubMed ID: 10400483
[TBL] [Abstract][Full Text] [Related]
19. Nimesulide-induced acute hepatitis.
Sbeit W; Krivoy N; Shiller M; Farah R; Cohen HI; Struminger L; Reshef R
Ann Pharmacother; 2001 Sep; 35(9):1049-52. PubMed ID: 11573855
[TBL] [Abstract][Full Text] [Related]
20. Concomitant use of low-dose methotrexate and NSAIDs and the risk of serious adverse events among patients with rheumatoid arthritis.
Svanström H; Lund M; Melbye M; Pasternak B
Pharmacoepidemiol Drug Saf; 2018 Aug; 27(8):885-893. PubMed ID: 29797447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
